A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease

NCT05730621 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarpogrelate
Blood Viscosity
Peripheral Arterial Disease
Coronary Artery Disease

Interventions

DRUG: Sarpogrelate Sustained Release/Aspirin
DRUG: Aspirin

Sponsor

Yuhan Corporation